Meda’s new Astepro Nasal Spray (an improvement of the already available Astelin) has received the approval of the U.S. Food and Drug Administration. The new product is better tolerated by patients, caused lesser discomfort and was not tha bitter too. On the other hand,  relief from symptoms improved. Azelastine, the nasal antihistamine used for treating rhinitis is the active substance in it.